Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
32.16
+0.05 (0.16%)
At close: Jul 3, 2025, 1:00 PM
32.30
+0.14 (0.44%)
After-hours: Jul 3, 2025, 3:51 PM EDT
HRMY Market Cap
HRMY has a market cap or net worth of $1.85 billion as of July 3, 2025. Its market cap has increased by 10.72% in one year.
Market Cap
1.85B
Enterprise Value
1.52B
1-Year Change
10.72%
Ranking
Category
Stock Price
$32.16
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.85B, an increase of 300.57%. That is a compound annual growth rate of 32.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 1.85B | -5.89% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | 2.06B | 346.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.78B |
| Johnson & Johnson | 375.30B |
| AbbVie | 335.39B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 282.66B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.38B |
| AstraZeneca | 219.33B |